PATENT CLAIM ANALYSIS

Application Number: 15905293
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "016000"]

Abstract:
The present invention relates to a carbohydrate-based peritoneal dialysis fluid, containing a compound selected from the group consisting of glutamine, preferably L-glutamine; a dipeptide capable of releasing glutamine, L-glutamine in free form, preferably selected from the group consisting of glutaminyl-glycine, glycinyl-glutamine, glutaminyl-alanine, alanyl-glutamine; an oligopeptide consisting of two to seven glutamine, preferably L-glutamine residues; and mixtures thereof. The peritoneal dialysis fluids of the present invention are useful for inhibition of technical failure in a person undergoing peritoneal dialysis treatment.

Claim (Index 11):
The peritoneal dialysis fluid and/or compound according to  claim 9  for the specific use of prevention of peritoneal membrane failure, attenuation of barrier dysfunction and prevention of mesothelial cell detachment.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 88.0
- Lexical Diversity: 1.76923
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14081835', '14369071', '13779362', '13829163', '10839017']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.76885965644253
- 35 USC 102 Novelty (BERT): 0.5545130509354737
- Combined Prediction Score: 0.7474249958918243
- Mean Citation Score: 257.234796
- Max Citation Score: 439.943
- Similarity Product: 300.86891431492563

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test